Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Crescita Therapeutics Ord (OP:CRRTF)

0.3663 UNCHANGED
Last Price Updated: 3:24 PM EST, Jan 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.3663
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.3663
Today's Range 0.3663 - 0.3663
52wk Range 0.0210 - 0.4052
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Crescita Reports Second Quarter 2025 Results
From Crescita Therapeutics Inc.
Via Business Wire
News headline image
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
From Crescita Therapeutics Inc.
Via Business Wire

Performance

YTD
+7.7%
+7.7%
1 Month
+10.6%
+10.6%
3 Month
+17.2%
+17.2%
6 Month
+5.5%
+5.5%
1 Year
-6.1%
-6.1%

More News

Read More
News headline image
Crescita Therapeutics Announces Mutual Termination of Licensing Agreement with Croma Pharma GmbH for Pliaglis®
From Crescita Therapeutics
Via Business Wire
News headline image
Crescita Reports First Quarter 2025 Results
From Crescita Therapeutics Inc.
Via Business Wire
News headline image
Crescita Reports Q4 and Fiscal 2024 Results
From Crescita Therapeutics
Via Business Wire
News headline image
Crescita Reports Third Quarter 2024 Results
From Crescita Therapeutics
Via Business Wire
News headline image
Crescita Therapeutics Announces Approval of Normal Course Issuer Bid
From Crescita Therapeutics
Via Business Wire
News headline image
Crescita to Present & Participate in 1x1 Meetings at the Planet MicroCap Showcase: VANCOUVER 2024 in Association with Small Cap Discoveries on Thursday, September 26, 2024
From Crescita Therapeutics
Via Business Wire
News headline image
Crescita Reports Second Quarter 2024 Results
From Crescita Therapeutics
Via Business Wire
News headline image
Crescita Secures Contract Manufacturing Revenue of $US10 Million Over 4 Years
From Crescita Therapeutics
Via Business Wire
News headline image
Leading Canadian Healthcare Services Provider Selects Crescita as Exclusive Manufacturing Partner under 5-Year Agreement
From Crescita Therapeutics
Via Business Wire
News headline image
Crescita Expands Medical Aesthetic Portfolio with MicronJetTM600 The World’s Smallest Intradermal Delivery Device
From Crescita Therapeutics
Via Business Wire
News headline image
Crescita Completes Acquisition of Strategic Assets of Occy Laboratory
From Crescita Therapeutics
Via Business Wire
News headline image
Crescita to Acquire Strategic Assets of Occy Laboratory
From Crescita Therapeutics
Via Business Wire
News headline image
Crescita Reports First Quarter 2024 Results
From Crescita Therapeutics
Via Business Wire
News headline image
Crescita Reports Q4 and Fiscal 2023 Results
From Crescita Therapeutics
Via Business Wire
News headline image
Crescita Reports Third Quarter 2023 Results
From Crescita Therapeutics Inc.
Via Business Wire
News headline image
Crescita Therapeutics Announces Approval of Normal Course Issuer Bid
From Crescita Therapeutics
Via Business Wire
News headline image
Crescita Reports Second Quarter 2023 Results
From Crescita Therapeutics
Via Business Wire
News headline image
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
From Crescita Therapeutics
Via Business Wire
News headline image
Crescita Reports First Quarter 2023 Results
From Crescita Therapeutics Inc.
Via Business Wire
News headline image
Crescita Reports Q4 and Fiscal 2022 Results
From Crescita Therapeutics Inc.
Via Business Wire
News headline image
Crescita Reports Third Quarter 2022 Results
From Crescita Therapeutics Inc.
Via Business Wire
News headline image
Crescita Reports Second Quarter 2022 Results
From Crescita Therapeutics Inc.
Via Business Wire
News headline image
Crescita Therapeutics Announces the Results of its Annual General and Special Meeting of Shareholders
From Crescita Therapeutics
Via Business Wire

Frequently Asked Questions

Is Crescita Therapeutics Ord publicly traded?
Yes, Crescita Therapeutics Ord is publicly traded.
What exchange does Crescita Therapeutics Ord trade on?
Crescita Therapeutics Ord trades on the OTC Traded
What is the ticker symbol for Crescita Therapeutics Ord?
The ticker symbol for Crescita Therapeutics Ord is CRRTF on the OTC Traded
What is the current price of Crescita Therapeutics Ord?
The current price of Crescita Therapeutics Ord is 0.3663
When was Crescita Therapeutics Ord last traded?
The last trade of Crescita Therapeutics Ord was at 01/22/26 03:24 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.